NM_002185.5:c.2T>G
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1_SupportingPM2PP5_Very_Strong
The NM_002185.5(IL7R):c.2T>G(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.0000329 in 1,580,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_002185.5 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000242 AC: 6AN: 247786Hom.: 0 AF XY: 0.00000745 AC XY: 1AN XY: 134276
GnomAD4 exome AF: 0.0000336 AC: 48AN: 1427924Hom.: 0 Cov.: 26 AF XY: 0.0000239 AC XY: 17AN XY: 712668
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74358
ClinVar
Submissions by phenotype
Immunodeficiency 104 Pathogenic:2
- -
This sequence change affects the initiator methionine of the IL7R mRNA. The next in-frame methionine is located at codon 10. This variant is present in population databases (rs200076125, gnomAD 0.006%). Disruption of the initiator codon has been observed in individuals with severe combined immunodeficiency (PMID: 18641513; Invitae). ClinVar contains an entry for this variant (Variation ID: 948034). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Severe combined immunodeficiency disease Pathogenic:1
Variant summary: IL7R c.2T>G (p.Met1Arg) alters the initiation codon and is predicted to result either in absence of the protein or truncation of the encoded protein due to translation initiation at a downstream codon, with the next in-frame start codon at Met10. Three of three in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.4e-05 in 247786 control chromosomes. c.2T>G has been reported in the literature in individuals affected with Severe Combined Immunodeficiency in multiple homozygotes or in affected individuals with heterozygote or unreported genotypes (e.g. Lebet_2008, Strauss_2008, Bhattacharjee_2015, Cunningham-Rundles_2023). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 25255367, 18641513, 18442948, 38274105). ClinVar contains an entry for this variant (Variation ID: 948034). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at